We are live on ! Find out more
BGMS icon

Bio Green Med Solution

13 hedge funds and large institutions have $300K invested in Bio Green Med Solution in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

177,746% more capital inflows, than outflows

Capital inflows: $292K | Capital outflows: $164

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

44% more funds holding

Funds holding: 9 → 13 (+4)

34.7% more ownership

Funds ownership: 13.86% → 48.56% (+35%)

Holders
13
Holders Change
+4
Holders Change %
+44.44%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BGMS Hedge Fund Activity: Q4 2024 in Review

13 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution (BGMS) for Q4 2024, worth a combined $300K — up 50% from $200K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BGMS positions and 1 closed out — a net gain of 4 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, adding an estimated $251K. The largest seller was McIlrath & Eck, exiting entirely with an estimated $164 sold.

  • 13 institutional investors held Bio Green Med Solution (BGMS) as of Q4 2024, up from 9 in Q3 2024.
  • Funds reported $300K of Bio Green Med Solution stock for Q4 2024, up 50% quarter-over-quarter.
  • 5 funds opened new Bio Green Med Solution positions in Q4 2024 and 1 closed out, a net change of +4 holders.
  • The largest Bio Green Med Solution buyer in Q4 2024 was Armistice Capital, an estimated $251K added.
  • The largest Bio Green Med Solution seller in Q4 2024 was McIlrath & Eck, an estimated $164 sold.

Based on aggregated 13F filings for Q4 2024.